BIOSONDA S.A.
The company is recognized as a global leader in the production of mollusk hemocyanins. These proteins act as carriers for generating monoclonal and polyclonal antibodies to peptides and haptens and also serve as nonspecific protein-based adjuvants in experimental human and veterinary vaccines.
Research and Applications
Biosonda S.A. is ainmunopharmaceutical company, focused in the research production and commercialization of hemocyanins, for the development of cancer vaccines, adjuvants and for the production of antibodies to haptens and peptides.